vTv Therapeutics Inc (VTVT)
24.74
+0.59
(+2.44%)
USD |
NASDAQ |
Apr 18, 16:00
24.99
+0.25
(+1.01%)
Pre-Market: 20:00
vTv Therapeutics Enterprise Value: 57.07M for April 18, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 18, 2024 | 57.07M |
| April 17, 2024 | 55.63M |
| April 16, 2024 | 55.58M |
| April 15, 2024 | 57.70M |
| April 12, 2024 | 56.55M |
| April 11, 2024 | 58.70M |
| April 10, 2024 | 58.43M |
| April 09, 2024 | 57.70M |
| April 08, 2024 | 57.70M |
| April 05, 2024 | 58.14M |
| April 04, 2024 | 58.92M |
| April 03, 2024 | 57.97M |
| April 02, 2024 | 59.04M |
| April 01, 2024 | 58.19M |
| March 28, 2024 | 54.12M |
| March 27, 2024 | 54.78M |
| March 26, 2024 | 53.05M |
| March 25, 2024 | 49.40M |
| March 22, 2024 | 48.53M |
| March 21, 2024 | 67.43M |
| March 20, 2024 | 61.76M |
| March 19, 2024 | 47.72M |
| March 18, 2024 | 45.83M |
| March 15, 2024 | 40.67M |
| March 14, 2024 | 38.36M |
| Date | Value |
|---|---|
| March 13, 2024 | 35.90M |
| March 12, 2024 | 35.73M |
| March 11, 2024 | 33.42M |
| March 08, 2024 | 32.25M |
| March 07, 2024 | 33.03M |
| March 06, 2024 | 32.64M |
| March 05, 2024 | 30.30M |
| March 04, 2024 | 30.96M |
| March 01, 2024 | 38.28M |
| February 29, 2024 | 40.78M |
| February 28, 2024 | 38.53M |
| February 27, 2024 | 18.14M |
| February 26, 2024 | 14.00M |
| February 23, 2024 | 14.31M |
| February 22, 2024 | 15.04M |
| February 21, 2024 | 14.93M |
| February 20, 2024 | 16.80M |
| February 16, 2024 | 16.95M |
| February 15, 2024 | 16.91M |
| February 14, 2024 | 17.08M |
| February 13, 2024 | 18.37M |
| February 12, 2024 | 18.84M |
| February 09, 2024 | 18.56M |
| February 08, 2024 | 18.14M |
| February 07, 2024 | 17.73M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
13.32M
Minimum
Jan 25 2024
252.25M
Maximum
Apr 13 2021
106.03M
Average
92.65M
Median
Enterprise Value Benchmarks
| Altimmune Inc | 291.36M |
| Palatin Technologies Inc | 21.01M |
| Oragenics Inc | 3.485M |
| Viking Therapeutics Inc | 6.143B |
| G1 Therapeutics Inc | 186.55M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.478M |
| Total Expenses (Quarterly) | 4.707M |
| EPS Diluted (Quarterly) | -1.31 |
| Earnings Yield | -39.25% |
| Normalized Earnings Yield | -40.42 |